You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AZELAIC ACID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Azelaic Acid

A generic version of AZELAIC ACID was approved as azelaic acid by ACTAVIS LABS UT INC on November 19th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZELAIC ACID?
  • What are the global sales for AZELAIC ACID?
  • What is Average Wholesale Price for AZELAIC ACID?
Drug patent expirations by year for AZELAIC ACID
Drug Prices for AZELAIC ACID

See drug prices for AZELAIC ACID

Recent Clinical Trials for AZELAIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Insel Gruppe AG, University Hospital BernPhase 2
Chang Gung Memorial HospitalPhase 1/Phase 2
South Valley UniversityN/A

See all AZELAIC ACID clinical trials

Pharmacology for AZELAIC ACID
Paragraph IV (Patent) Challenges for AZELAIC ACID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FINACEA Topical Foam azelaic acid 15% 207071 1 2017-09-14
FINACEA Gel azelaic acid 15% 021470 1 2012-07-27

US Patents and Regulatory Information for AZELAIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa AZELAIC ACID azelaic acid AEROSOL, FOAM;TOPICAL 210928-001 Oct 7, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Speclt AZELAIC ACID azelaic acid GEL;TOPICAL 204637-001 Nov 19, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Labs Ut Inc AZELAIC ACID azelaic acid GEL;TOPICAL 208011-001 Nov 19, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.